2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on CRC: Can We Consider Pembrolizumab a New First Line SoC in Patients With MSI-H mCRC?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shikha Jain
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shikha Jain
559 views
July 14, 2020
Comments 0
Login to view comments.
Click here to Login
GI